DANIELLE BLAINE: Open Payments
NPI 1811760432 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 43 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $585 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $196 |
| Evofem Biosciences, Inc. | 6 | $105 |
| Biogen, Inc. | 4 | $104 |
| Exact Sciences Corporation | 4 | $100 |
| Exeltis, USA Inc. | 5 | $98 |
| Organon LLC | 4 | $80 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $69 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| CooperSurgical, Inc. | 1 | $21 |
Products named: Veozah, Phexxi, ZURZUVAE, Cologuard Collection Kit, SLYND, NEXPLANON, MYFEMBREE, GARDASIL 9.
Industry payments across NJ — which companies pay providers there.
